Webinar Castor Product Spotlight: What’s new in 2024? In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards. Also get a first look at whats planned for later in 2024 Learn more
Webinar Achieving Post-Market Success: Harnessing RWE for Accelerated Market Acceptance Watch our on-demand webinar featuring CVS Healthspire™ Life Sciences Solutions Learn more
Webinar Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay Shah, Chief Medical Officer at Aktiia Learn more
Webinar ePRO and Cancer Research: Measuring the true patient experience In this on-demand webinar, we delve into the nuances of measuring true QOL & PRO for oncology trials. Learn more
Webinar The impact of ePRO on the patient & site journeys Watch the recording of our product webinar on the impact of electronic Patient Reported Outcomes (ePRO) from two important lenses: the patient and the site. Learn more
Webinar From Paper to ePRO: Bringing flexibility & efficiency to your clinical trials In this on demand webinar discover if your protocol is a good candidate for ePRO, and why implementing an ePRO solution instead of using paper questionnaires will make your trial more patient-centric and efficient for sponsors and sites Learn more
Webinar Product Spotlight: Dive deep into Castor’s eConsent This product spotlight webinar will help you gain a deeper understanding of Castor’s eConsent capabilities for patients, sponsors and sites. Learn more
Webinar Navigating successful eConsent adoption from sponsor to site Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent adoption from sponsor to site. Learn more
Webinar Product Spotlight: Castor ePRO In this on-demand webinar we dive into the benefits and capabilities of ePRO, and how Castor’s web and mobile ePRO applications empower your hybrid or decentralized trial. Learn more
